4 unknown, 2 completed. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Unknown 4, Completed 2 |
Follow Thrombopoietin: new trials by email Literature Review of Thrombopoietin trials Research Report on Thrombopoietin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts rhTPO, Eltrombopag - Previously Treated Primary Immune Thrombocytopenia | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 157 | 2022-11-22 | 2025-04-24 |
| Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury rhTPO, Control - Cancer Treatment Induced Thrombocytopenia | Phase 4 | Unknown | The First Affiliated Hospital of Dalian Medical University | 165 | 2022-06-06 | 2024-03-01 |
| Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients recombinant human thrombopoietin, normal saline - Pneumonia, Thrombocytopenia | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 178 | 2022-02-01 | 2022-02-01 |
| High-dose Use of rhTPO in CIT Patients rhTPO - Thrombocytopenia | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 50 | 2018-09-28 | 2018-10-30 |
| Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients recombinant human thrombopoietin - Thrombocytopenia | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 58 | 2014-10-01 | 2025-05-30 |
| Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT Recombinant Human Thrombopoietin (rHTPO) - Allogeneic Hematopoietic Stem Cell Transplantation, Myeloablative | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 80 | 2010-06-01 | 2015-10-09 |
Thrombocytopenia (3) · Pneumonia (1) · Purpura, Thrombocytopenic, Idiopathic (1)
Institute of Hematology & Blood Diseases Hospital, China (2) · Nanfang Hospital, Southern Medical University (2) · First Affiliated Hospital Xi'an Jiaotong University (1) · The First Affiliated Hospital of Dalian Medical University (1)
China (5)
Jianxiang Wang, Dr (1) · Jing Sun, MD (1) · Lei Zhang, MD (1) · Lingxiao Zhang, doctor (1) · Yunlong Xia, MD,PhD (1)